Metraipolis › archive › dc_c9e6ca488be1

Clinical Significance of CD90(+) Circulating Tumor Cells as Dynamic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab/Bevacizumab… — Europe PMC PMID:40940925

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40940925
DOI
10.3390/cancers17172829
License (as archived)
solo-consultazione
Archived
2026-11-10T06:45:27.277Z
SHA-256 of the archived text
880f0fe74144120164d239de0762186edea58b4804e6686176b4571965deb0de
Stable URL of this page
https://metraipolis.com/documento/dc_c9e6ca488be1

How to cite

Clinical Significance of CD90(+) Circulating Tumor Cells as Dynamic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab/Bevacizumab… — Europe PMC PMID:40940925 — Europe PMC (en), https://europepmc.org/article/MED/40940925 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c9e6ca488be1 (Metraipolis archive dc_c9e6ca488be1, sha256 880f0fe74144120164d239de0762186edea58b4804e6686176b4571965deb0de)
BibTeX
@misc{dcc9e6ca488be1,
  title = {Clinical Significance of CD90(+) Circulating Tumor Cells as Dynamic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab/Bevacizumab… — Europe PMC PMID:40940925},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40940925},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c9e6ca488be1; sha256 880f0fe74144120164d239de0762186edea58b4804e6686176b4571965deb0de},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40940925. Agents can read the archived copy with the MCP tool read_document.